• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    United Therapeutics Corporation To Report Third Quarter 2016 Financial Results

    Written by Chelsea Pratt
    |
    Oct. 20, 2016 04:16AM PST

    United Therapeutics Corporation announced today that it will report its third quarter 2016 financial results before the market opens on Thursday, October 27, 2016.

    United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2016 financial results before the market opens on Thursday, October 27, 2016.
    United Therapeutics will host a half-hour teleconference on Thursday, October 27, 2016, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using access code: 94365649.


    This teleconference is also being webcast and can be accessed via United Therapeutics’ website at https://ir.unither.com/events.cfm.  [uthr-g]
    United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases.
    To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-report-third-quarter-2016-financial-results-before-the-market-opens-on-thursday-october-27-2016-300347904.html
    SOURCE United Therapeutics Corporation

    Related Links

    https://www.unither.com

    financial resultsunited therapeutics
    The Conversation (0)

    Go Deeper

    AI Powered

    uniQure N.V.

    United Therapeutics

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES